S&P 500   3,203.37 (-0.72%)
DOW   26,715.72 (-0.57%)
QQQ   257.38 (-1.35%)
AAPL   384.48 (-1.64%)
MSFT   203.87 (-2.00%)
FB   238.95 (-0.55%)
GOOGL   1,501.37 (-1.02%)
AMZN   2,962.01 (-1.56%)
NVDA   401.90 (-1.76%)
CGC   17.87 (-1.54%)
BABA   243.70 (-2.21%)
MU   49.92 (-1.17%)
GE   7.12 (-0.28%)
TSLA   1,492.97 (-3.43%)
AMD   54.24 (-1.99%)
T   30.28 (+0.90%)
ACB   12.15 (-5.59%)
F   6.83 (+1.34%)
GILD   75.97 (-0.89%)
DIS   119.33 (-1.30%)
NFLX   517.20 (-1.16%)
BAC   23.99 (-2.48%)
BA   181.52 (-3.42%)
S&P 500   3,203.37 (-0.72%)
DOW   26,715.72 (-0.57%)
QQQ   257.38 (-1.35%)
AAPL   384.48 (-1.64%)
MSFT   203.87 (-2.00%)
FB   238.95 (-0.55%)
GOOGL   1,501.37 (-1.02%)
AMZN   2,962.01 (-1.56%)
NVDA   401.90 (-1.76%)
CGC   17.87 (-1.54%)
BABA   243.70 (-2.21%)
MU   49.92 (-1.17%)
GE   7.12 (-0.28%)
TSLA   1,492.97 (-3.43%)
AMD   54.24 (-1.99%)
T   30.28 (+0.90%)
ACB   12.15 (-5.59%)
F   6.83 (+1.34%)
GILD   75.97 (-0.89%)
DIS   119.33 (-1.30%)
NFLX   517.20 (-1.16%)
BAC   23.99 (-2.48%)
BA   181.52 (-3.42%)
S&P 500   3,203.37 (-0.72%)
DOW   26,715.72 (-0.57%)
QQQ   257.38 (-1.35%)
AAPL   384.48 (-1.64%)
MSFT   203.87 (-2.00%)
FB   238.95 (-0.55%)
GOOGL   1,501.37 (-1.02%)
AMZN   2,962.01 (-1.56%)
NVDA   401.90 (-1.76%)
CGC   17.87 (-1.54%)
BABA   243.70 (-2.21%)
MU   49.92 (-1.17%)
GE   7.12 (-0.28%)
TSLA   1,492.97 (-3.43%)
AMD   54.24 (-1.99%)
T   30.28 (+0.90%)
ACB   12.15 (-5.59%)
F   6.83 (+1.34%)
GILD   75.97 (-0.89%)
DIS   119.33 (-1.30%)
NFLX   517.20 (-1.16%)
BAC   23.99 (-2.48%)
BA   181.52 (-3.42%)
S&P 500   3,203.37 (-0.72%)
DOW   26,715.72 (-0.57%)
QQQ   257.38 (-1.35%)
AAPL   384.48 (-1.64%)
MSFT   203.87 (-2.00%)
FB   238.95 (-0.55%)
GOOGL   1,501.37 (-1.02%)
AMZN   2,962.01 (-1.56%)
NVDA   401.90 (-1.76%)
CGC   17.87 (-1.54%)
BABA   243.70 (-2.21%)
MU   49.92 (-1.17%)
GE   7.12 (-0.28%)
TSLA   1,492.97 (-3.43%)
AMD   54.24 (-1.99%)
T   30.28 (+0.90%)
ACB   12.15 (-5.59%)
F   6.83 (+1.34%)
GILD   75.97 (-0.89%)
DIS   119.33 (-1.30%)
NFLX   517.20 (-1.16%)
BAC   23.99 (-2.48%)
BA   181.52 (-3.42%)
Log in

NASDAQ:VRCAVerrica Pharmaceuticals News Headlines

$8.24
+0.32 (+4.04 %)
(As of 07/16/2020 12:25 PM ET)
Add
Compare
Today's Range
$8.12
Now: $8.24
$8.41
50-Day Range
$8.76
MA: $11.84
$15.12
52-Week Range
$6.79
Now: $8.24
$18.67
Volume2,181 shs
Average Volume147,120 shs
Market Capitalization$212.67 million
P/E RatioN/A
Dividend YieldN/A
Beta2.37

Headlines

Verrica Pharmaceuticals (NASDAQ VRCA) News Headlines

Source:
DateHeadline
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess ...SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess ...
www.businesswire.com - July 16 at 9:46 AM
Verrica Pharmaceuticals (NASDAQ:VRCA) Downgraded to "Neutral" at Bank of AmericaVerrica Pharmaceuticals (NASDAQ:VRCA) Downgraded to "Neutral" at Bank of America
www.americanbankingnews.com - July 16 at 5:37 AM
Verrica Pharmaceuticals (NASDAQ:VRCA) Downgraded to "Neutral" at BofA SecuritiesVerrica Pharmaceuticals (NASDAQ:VRCA) Downgraded to "Neutral" at BofA Securities
www.americanbankingnews.com - July 16 at 5:37 AM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - July 15 at 11:09 PM
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) InvestorsINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors
finance.yahoo.com - July 15 at 1:08 PM
Verrica Pharmaceuticals (NASDAQ:VRCA) Lowered to Neutral at BofA SecuritiesVerrica Pharmaceuticals (NASDAQ:VRCA) Lowered to Neutral at BofA Securities
www.marketbeat.com - July 15 at 8:16 AM
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The FirmLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The Firm
feeds.benzinga.com - July 15 at 12:45 AM
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The FirmLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The Firm
finance.yahoo.com - July 15 at 12:35 AM
VERRICA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmVERRICA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - July 14 at 7:34 PM
Portnoy Law: Lawsuit Filed On Behalf of Verrica Pharmaceuticals Inc. InvestorsPortnoy Law: Lawsuit Filed On Behalf of Verrica Pharmaceuticals Inc. Investors
feeds.benzinga.com - July 14 at 6:51 PM
VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.
finance.yahoo.com - July 14 at 2:33 PM
VRCA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the FirmVRCA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - July 14 at 2:33 PM
Verrica strikes out on U.S. application for VP-102 for infectious skin diseaseVerrica strikes out on U.S. application for VP-102 for infectious skin disease
seekingalpha.com - July 14 at 9:32 AM
Verrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum ContagiosumVerrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
finance.yahoo.com - July 14 at 9:32 AM
Verrica (VRCA) in Focus: Stock Moves 8.9% HigherVerrica (VRCA) in Focus: Stock Moves 8.9% Higher
finance.yahoo.com - July 13 at 1:12 PM
The Law Offices of Frank R. Cruz Continues Its Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of InvestorsThe Law Offices of Frank R. Cruz Continues Its Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
finance.yahoo.com - July 9 at 1:20 PM
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of InvestorsGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
finance.yahoo.com - July 8 at 2:58 PM
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of InvestorsGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
www.businesswire.com - July 8 at 2:02 PM
Short Interest in Verrica Pharmaceuticals Inc (NASDAQ:VRCA) Grows By 5.6%Short Interest in Verrica Pharmaceuticals Inc (NASDAQ:VRCA) Grows By 5.6%
www.americanbankingnews.com - July 8 at 9:06 AM
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of InvestorsINVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
finance.yahoo.com - July 7 at 6:29 PM
Shareholder Alert: Robbins LLP Announces It Is Investigating the Officers and Directors of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of ShareholdersShareholder Alert: Robbins LLP Announces It Is Investigating the Officers and Directors of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Shareholders
www.businesswire.com - July 6 at 8:15 PM
Analysts Offer Predictions for Verrica Pharmaceuticals Incs Q2 2020 Earnings (NASDAQ:VRCA)Analysts Offer Predictions for Verrica Pharmaceuticals Inc's Q2 2020 Earnings (NASDAQ:VRCA)
www.americanbankingnews.com - July 2 at 6:45 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCASHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA
finance.yahoo.com - July 1 at 10:57 PM
VRCA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the FirmVRCA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - July 1 at 5:57 PM
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Verrica Pharmaceuticals Inc. Investors (VRCA)The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Verrica Pharmaceuticals Inc. Investors (VRCA)
finance.yahoo.com - June 30 at 7:38 PM
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of InvestorsGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
finance.yahoo.com - June 30 at 7:38 PM
Why a West Chester pharma firms stock opened down 22% TuesdayWhy a West Chester pharma firm's stock opened down 22% Tuesday
www.bizjournals.com - June 30 at 2:33 PM
Why Verrica Pharmaceuticals Stock Is Trading Lower TodayWhy Verrica Pharmaceuticals Stock Is Trading Lower Today
www.msn.com - June 30 at 2:33 PM
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of InvestorsINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
finance.yahoo.com - June 30 at 2:33 PM
Needham & Company LLC Trims Verrica Pharmaceuticals (NASDAQ:VRCA) Target Price to $17.00Needham & Company LLC Trims Verrica Pharmaceuticals (NASDAQ:VRCA) Target Price to $17.00
www.americanbankingnews.com - June 30 at 9:56 AM
The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Mercks Keytruda, OncoCyte Stalls Lung Nodule Malignancy TestThe Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
www.msn.com - June 30 at 9:33 AM
Verrica Pharmaceuticals (NASDAQ:VRCA) PT Lowered to $18.00 at HC WainwrightVerrica Pharmaceuticals (NASDAQ:VRCA) PT Lowered to $18.00 at HC Wainwright
www.americanbankingnews.com - June 30 at 9:22 AM
Verrica hits pothole with U.S. application for lead candidateVerrica hits pothole with U.S. application for lead candidate
seekingalpha.com - June 29 at 6:23 PM
Verrica Pharmaceuticals Provides Regulatory Update on VP-102Verrica Pharmaceuticals Provides Regulatory Update on VP-102
finance.yahoo.com - June 29 at 6:23 PM
Zacks: Brokerages Anticipate Verrica Pharmaceuticals Inc (NASDAQ:VRCA) to Announce -$0.44 EPSZacks: Brokerages Anticipate Verrica Pharmaceuticals Inc (NASDAQ:VRCA) to Announce -$0.44 EPS
www.americanbankingnews.com - June 27 at 11:31 AM
Northland Capital Markets Initiates Coverage On Verrica Pharmaceuticals with Outperform Rating, Announces Price Target of $21Northland Capital Markets Initiates Coverage On Verrica Pharmaceuticals with Outperform Rating, Announces Price Target of $21
www.benzinga.com - June 25 at 1:04 AM
Verrica Pharmaceuticals Inc (NASDAQ:VRCA) Given Consensus Rating of "Buy" by AnalystsVerrica Pharmaceuticals Inc (NASDAQ:VRCA) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - June 24 at 11:24 AM
Verrica Pharmaceuticals (NASDAQ:VRCA) Now Covered by Northland SecuritiesVerrica Pharmaceuticals (NASDAQ:VRCA) Now Covered by Northland Securities
www.americanbankingnews.com - June 24 at 10:46 AM
Verrica Pharmaceuticals Announces Positive Results from Two New Pooled Analyses of the Phase 3 CAMP Trials of VP-102 in Molluscum ContagiosumVerrica Pharmaceuticals Announces Positive Results from Two New Pooled Analyses of the Phase 3 CAMP Trials of VP-102 in Molluscum Contagiosum
finance.yahoo.com - June 12 at 1:29 PM
Verrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of DirectorsVerrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors
finance.yahoo.com - June 10 at 8:26 AM
Hedge Funds Never Been Less Bullish On Verrica Pharmaceuticals Inc. (VRCA)Hedge Funds Never Been Less Bullish On Verrica Pharmaceuticals Inc. (VRCA)
finance.yahoo.com - May 27 at 7:11 PM
Verrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare ConferenceVerrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
finance.yahoo.com - May 27 at 9:10 AM
Verrica Pharmaceuticals Reports First Quarter 2020 Financial ResultsVerrica Pharmaceuticals Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 7 at 7:29 AM
Verrica Pharmaceuticals to Participate in the 19th Annual Needham Virtual Healthcare ConferenceVerrica Pharmaceuticals to Participate in the 19th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 9 at 5:49 PM
Verrica Pharmaceuticals EPS misses by $0.02Verrica Pharmaceuticals EPS misses by $0.02
seekingalpha.com - March 13 at 9:43 AM
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial ResultsVerrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
finance.yahoo.com - March 13 at 9:43 AM
Verrica Pharma secures $55M in debt capitalVerrica Pharma secures $55M in debt capital
seekingalpha.com - March 11 at 2:41 PM
Verrica Pharmaceuticals Secures $55 Million in Loan Facilities Led by Silicon Valley BankVerrica Pharmaceuticals Secures $55 Million in Loan Facilities Led by Silicon Valley Bank
finance.yahoo.com - March 11 at 8:05 AM
Verrica Pharmaceuticals to Attend Several Upcoming Investor ConferencesVerrica Pharmaceuticals to Attend Several Upcoming Investor Conferences
finance.yahoo.com - February 20 at 2:24 PM
Verrica Pharmaceuticals Announces the Hiring of Two Vice Presidents to Further Grow its Commercial CapabilitiesVerrica Pharmaceuticals Announces the Hiring of Two Vice Presidents to Further Grow its Commercial Capabilities
finance.yahoo.com - January 29 at 10:51 AM
This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.